Middle East and Africa PDX Models Market which was USD 36424.39 thousand in 2022, is expected to reach USD 87014.42 thousand by 2030, at a CAGR of 11.5% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

 

Key Drivers

The key drivers of the Patient-Derived Xenograft/PDX Model market are the increasing incidence of cancer, the availability of PDX models for a wide range of cancer types, and the increasing use of PDX models in drug development. The incidence of cancer is increasing globally, with an estimated 18.1 million new cases and 9.6 million cancer-related deaths in 2018. The availability of PDX models for a wide range of cancer types is a key driver of the PDX market. PDX models are available for a variety of solid tumors, including breast, lung, colorectal, and pancreatic cancer, as well as for hematologic malignancies such as leukemia and lymphoma. The use of PDX models in drug development is increasing, as they provide a more accurate representation of the human disease than cell line-derived xenografts (CDXs). PDX models are being used in a variety of drug development applications, including target validation, preclinical efficacy testing, and toxicity testing.

 

Get Exclusive Sample Report-@ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=middle-east-and-africa-pdx-models-market

Type

  • Mice Models
  • Rat Models

Tumor Type

  • Gastrointestinal Tumor Models
  • Lung Tumor Models
  • Haematological Tumor Models
  • Gynecological Tumor Models
  • Respiratory Tumor Models
  • Urological Tumor Models
  • Others

Application

  • Preclinical Drug Development
  • Precision Medicine
  • Co-Clinical Trials
  • Basic Cancer Research
  • Biomarker Analysis
  • Oncology Research

Technique

  • Heterotopic Implantation
  • Orthotropic Implantation

End User

  • Academic and Research Organizations
  • Contract Research Organizations
  • Pharmaceutical and Biotechnological Companies
  • Others

Some of the key areas where PDX models are used include:

  1. Cancer Biology Research: PDX models are used to study the biology of tumors and their behavior in vivo. They enable researchers to investigate tumor heterogeneity, tumor-stroma interactions, and the mechanisms of tumor progression and metastasis.
  2. Drug Development: PDX models are used to evaluate the efficacy and safety of new cancer therapies. They enable researchers to identify new drug targets and test the efficacy of new drug candidates in vivo, providing a more accurate prediction of how drugs will behave in humans.
  3. Overall, the scope of Global Patient Derived Xenograft (PDX) Models is broad and includes a wide range of applications in cancer research and drug development. PDX models are a valuable tool for cancer researchers, oncologists, and drug developers, enabling them to better understand tumor biology and develop more effective cancer therapies

Highlight of Table of Content:

§  Chapter 1: Market overview

§  Chapter 2: Middle East and Africa PDX Models Market Analysis

§  Chapter 3: Regional analysis of the Middle East and Africa PDX Models Market

§  Chapter 4: Market segmentation based on types and applications

§  Chapter 5: Revenue analysis based on types and applications

§  Chapter 6: Market share

§  Chapter 7: Competitive Landscape

§  Chapter 8: Drivers, Restraints, Challenges, and Opportunities

§  Chapter 9: Gross Margin and Price Analysis

Some of the major players operating in the patient derived xenograft (PDX) models market are:

  • Crown Bioscience Inc. (U.S.)
  • THE JACKSON LABORATORY (U.S.)
  • Champions Oncology, Inc. (U.S.)
  • Charles River Laboratories (U.S.)
  • Wuxi AppTec (China)
  • Oncodesign (Canada)
  • Aragen Bioscience (India)
  • Biocytogen (U.S.)
  • Bioduro (U.S.)
  • Creative Animodel (U.S.)
  • Covance Inc. (U.S.)
  • EPO Berlin-Buch GmbH (Germany)
  • EUROPDX. (Belgium)

 

Profound Questions Answered in this Report:

·        What is the growth rate of various stages in the value chain of the industry?

·        Which region has the highest growth rate and size of the emerging market by value in 2022?

·        Who are the competitive players in Middle East and Africa PDX Models Market?

·        Which region has the largest share and degree of competition in the industry?

·        What is the CAGR of the market during the forecast period 2023 to 2030?

·        Which region is expected to hold the highest market share for the market?

·        What is the main driver of the Middle East and Africa PDX Models Market?

·        What is sales volume, revenue, and price analysis of top players of the market?

·        What are the market opportunities and threats faced by the vendors in the industry?

·        What has been the impact of COVID-19 on the Middle East and Africa PDX Models Market?

 

Asceses Full report@ https://www.databridgemarketresearch.com/reports/middle-east-and-africa-pdx-models-market

Related Report @-

https://www.databridgemarketresearch.com/reports/global-esophageal-cancer-market

https://www.databridgemarketresearch.com/reports/global-plastic-cards-market 

https://www.databridgemarketresearch.com/reports/global-digital-experience-platform-market

https://www.databridgemarketresearch.com/reports/europe-telehealth-market

 

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sopan.gedam@databridgemarketresearch.com